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Cervical Cancer Survival by Socioeconomic Status,
Race/Ethnicity, and Place of Residence in Texas,
1995–2001
KATHERINE S. EGGLESTON, M.S.P.H.,1 ANN L. COKER, Ph.D.,1
MELANIE WILLIAMS, Ph.D.,2 GUILLERMO TORTOLERO-LUNA, M.D., Ph.D.,1
JEANNE B. MARTIN, Ph.D., R.D., F.A.D.A., L.D.,1 and SUSAN R. TORTOLERO, Ph.D.1
ABSTRACT
Objective: The current study explored whether socioeconomic status (SES), race/ethnicity, and
rural residence may be linked to poorer cervical cancer survival by stage at diagnosis.
Methods: Data from 7,237 cervical cancer cases reported to the Texas Cancer Registry from
1995–2001 were used to address the association by stage at diagnosis and cause of death. Zip
code-level census data were used to classify residence and to develop a composite variable
for SES. Multilevel Cox proportional hazards modeling was used to estimate hazard ratios
(HR) and 95% confidence intervals (CI).
Results: Late stage at diagnosis was a strong predictor of cervical cancer mortality (HR 
6.2, 95% CI 5.5-7.2). SES and race/ethnicity were independently associated with stage at di-
agnosis. Women residing in areas with lower SES had significantly shorter survival times
when diagnosed at an early stage (HR  3.0, 95% CI 2.1-4.3). Hispanic women had a lower
probability of dying from cervical cancer during the follow-up period (HR  0.7, 95% CI 0.6-
0.8) after adjusting for confounders. The association between lower SES and poorer survival
was consistent across all racial/ethnic groups, suggesting the effect of SES may be more im-
portant than race
Conclusions: SES and race/ethnicity were independently associated with poorer cervical can-
cer survival in this large Texas sample. Further research is needed to investigate the role of
optimal treatment and comorbid conditions in the association between SES and cervical can-
cer survival.
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INTRODUCTION
DESPITE THE PREVENTABLE NATURE of cervicalcancer, an estimated 9710 women will be di-
agnosed and 3700 of these women will die from
this malignancy in the United States in 2006.1 His-
panic women have the highest age-adjusted cer-
vical cancer incidence, and African American wo-
men have the highest mortality rates compared
with non-Hispanic whites.1 Differences in so-
cioeconomic status (SES) by race/ethnicity may
explain observed racial differences in cervical
cancer incidence and mortality. 
SES is best described as a combination of highly
correlated yet distinct factors, including income,
education, occupation, and place of residence.2
1School of Public Health, University of Texas Health Science Center, Houston, Texas.
2Texas Department of State Health Services, Cancer Epidemiology and Surveillance Branch, Austin, Texas.
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Data from these factors are commonly used as
proxy variables to indicate overall SES. Among
studies examining SES indicators and sur-
vival,3–11 about one third5–7 found an association
between low SES and poorer cervical cancer sur-
vival after adjusting for race/ethnicity. In a large
cohort study, Singh et al.12 found that cervical
cancer mortality increased with increasing
poverty and lower education for women in each
racial/ethnic group examined. Using data from
the Military Healthcare System in which all wo-
men had similar access to care, Farley et al.3
found that neither race/ethnicity nor SES were
associated with cervical cancer survival. Almost
half of all studies addressing race/ethnicity and
survival without adjusting for SES9,13–20 con-
cluded that minority race/ethnicity was an im-
portant predictor of survival.13,14,16–18 However,
failure to adjust for SES may be responsible for
the apparent racial gap in survival that was ob-
served.
Fewer studies have addressed rural residence
as a proxy measure for access to care and cervi-
cal cancer survival.5,21 O’Brien et al.21 found that
women living in rural areas in Australia were at
higher risk of death than those living in metro-
politan areas (standardized mortality ratio 10.1),
suggesting lack of access to healthcare services.
In contrast, Johnson5 did not find this association
among South Carolina women after adjusting for
race/ethnicity, age, and poverty (adjusted hazard
ratio [HR]  1.10, 95% confidence interval [CI]
0.81-1.50).
The large population, ethnic diversity, and
high proportion of rural areas make Texas an op-
timal state to study the impact of socioeconomic
factors on cervical cancer survival. The purpose
of this study is to estimate cervical cancer sur-
vival by SES, rural residence, and race/ethnicity
while adjusting for confounders using multilevel
Cox proportional hazards modeling.
MATERIALS AND METHODS
Data for this population-based cohort study
were obtained from the Texas Cancer Registry
(TCR), which has a case completeness proportion
of 99%.22 Institutional Review Boards from the
Texas Department of State Health Services and
the University of Texas Health Science Center 
at Houston reviewed the study protocol and
deemed the project exempt. Eligible cases in-
cluded women 18 years reported to the TCR as
having an invasive primary cervical cancer diag-
nosis between January 1, 1995, and June 30, 2001.
Women with multiple primary cancers were ex-
cluded. Incident cases were linked with the Texas
Department of State Health Services mortality
data through December 21, 2001, to identify wo-
men with an incident cancer who died, along
with the date and underlying causes of death. All
women in whom cervical cancer was listed as an
underlying cause of death were used to estimate
cause-specific survival rates. Women who died
from other causes were censored.
Exposures: SES, rural residence, and
race/ethnicity
Data from the TCR and the U.S. Census 2000
were used to define three primary exposures:
SES, rural residence, and race/ethnicity. A com-
posite variable was created for SES using ZIP
code-level data for median income, poverty, ed-
ucation, and employment. Poverty was defined
as the percent of residents living in the ZIP code
of the cervical cancer patient whose incomes were
at or below the federal definition of poverty.23
Similarly, low education and unemployment
were defined as the percent of women living in
the ZIP code of the cervical cancer patient with
less than a high school education23 and who were
not in the labor force,24 respectively. As all other
variables comprising the composite variable are
percentages, median income was transformed
into a percent for purposes of consistency. Me-
dian income was defined as the percent differ-
ence between the median household income of
residents living in the ZIP code of the cervical
cancer patient and the median household income
for the state of Texas.23 The four indicator vari-
ables were summed to create the final SES com-
posite variable based on an accepted measure of
community-level SES.25–27 Analysis of the indi-
vidual components of the composite variable
showed satisfactory internal consistency (Cron-
bach’s alpha  0.71). Given that the percent dif-
ference ranged from negative to positive values
(corresponding to median incomes lesser and
greater than the median income for Texas), the fi-
nal composite variable was brought to a positive
distribution by adding the absolute value of the
largest negative value to the entire distribution.
SES was then categorized into quartiles based on
the distribution of the data.
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Rural residence was hypothesized to be a proxy
measure for access to healthcare, including prox-
imity to urban areas where cancer screening and
treatment services are more readily available. Rural
residence was also defined using ZIP code-level
data from the U.S. Census 2000, which indicates the
proportion of the ZIP code denoted as rural.28 This
variable was categorized into five groups based on
distribution of the Texas population: urban (0%
rural, referent group), midurban (11.66% rural),
rural (11.67%–23.32% rural), midrural (23.33%–
69.99% rural) and very rural (70% rural).
Race/ethnicity was defined by individual data
from two variables (race and Spanish/Hispanic
origin) abstracted from medical records by TCR
staff. This enabled us to classify those with a
Spanish/Hispanic origin who may report differ-
ent racial groups. Race/ethnicity was categorized
as white non-Hispanic (referent group), African
American, Hispanic, and other race/ethnicity
groups (Asian, other, and unknown). Of those
classified as Hispanic, 32.3% were Mexican,
57.2% were Spanish, Hispanic, or Latina, 7.2%
had a Spanish surname, 2.6% were other His-
panic, 0.4% were Central or South American,
0.2% were Puerto Rican, and 0.1% were Cuban.
No African American women reported a Span-
ish/Hispanic origin.
Outcome: Cervical cancer survival
The primary outcome was months of survival
following cervical cancer diagnosis. Subjects were
censored at the end of the follow-up on Decem-
ber 31, 2001. Data characterizing stage at diag-
noses were obtained from the TCR and reported
using the Surveillance, Epidemiology and End
Results (SEER) summary staging guide. Stage at
diagnosis was classified into two categories: early
and late stage. Early stage is classified as local-
ized only and corresponds to International Fed-
eration of Gynecology and Obstetrics (FIGO)
staging by including stages I, IA1, IA2, and IB.
Late stage is classified as regional or invasive car-
cinoma and likewise corresponds to FIGO stages
IIA, IIB, IIA, III, and IV.29 Stage of diagnosis was
evaluated as an effect measure modifier because
the impact of poverty, rural residence or race/
ethnicity on survival may differ by stage.
Statistical methods
All data were analyzed using the statistical
software package Intercooled Stata version 8.0.
As stage at diagnosis is a strong predictor of sur-
vival, we used multivariate logistic regression to
determine if the socioeconomic composite vari-
able, rural residence, and race/ethnicity were as-
sociated with late stage at diagnosis. All women
who were missing on stage at diagnosis (n 
1241) were excluded from analyses because of the
strong impact of stage on survival. Potential con-
founders included age, year of diagnosis, and
cancer cell type.
Multilevel Cox proportional hazards modeling
was used to estimate the relative risk of dying
from cervical cancer associated with SES, rural
residence, and race/ethnicity. The Breslow-Day
test for homogeneity, as a measure of effect mod-
ification of stage on SES and survival, was sig-
nificant (chi-square  7.37, p  0.001); therefore,
all analyses were conducted by stage (early stage
I–IB, late stage IIA–IV). An additional model,
where stage was treated as a confounder, was
also employed. Analyses were conducted for cer-
vical cancer-specific mortality, in which women
dying from other causes were excluded. Survival
curves were generated using the Kaplan-Meier
procedure and compared using the log-rank test.
Although cervical cancer cell type was evaluated
as a potential confounder due to differences in
survival and efficacy of screening among women
with adenocarcinoma, it did not meet the opera-
tional definition of a confounder in a cohort
study. All final models included the primary ex-
posures of interest: composite SES, rural resi-
dence, race/ethnicity, and age.
RESULTS
Table 1 provides the descriptive characteris-
tics of all 7237 women diagnosed with primary
invasive cervical cancer from January 1, 1995, to
June 30, 2001, and reported to the TCR. Of those
with data on stage at diagnosis, the majority of
patients were diagnosed in the early stage 
(59.2%) with squamous cell carcinomas (72%).
The mean age of women diagnosed with cervi-
cal cancer was 50.0  16.2 years, with almost
two thirds of women diagnosed before age 55.
Over 30% of women diagnosed with cervical
cancer reported a Spanish/Hispanic origin, and
approximately 14% were African American
(Table 1). Twenty-eight percent (n  2029) of
the cohort died during the follow-up period. Al-
most 73% of women who died with information
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on stage at diagnosis were diagnosed with late
stage disease.
Table 2 shows the association between the com-
posite SES variable, rural residence, race/ethnic-
ity, and stage of cervical cancer diagnosis. Pa-
tients with missing staging information (n 
1169), no available ZIP code data (n  116), and
with other/unknown race/ethnicity (n  162)
were excluded, leaving 5790 women for logistic
regression analysis. After adjusting for race/eth-
nicity, rural residence, and age, women living in
ZIP codes with lower SES were more likely to be
diagnosed at a later stage. The trend test of
greater proportion late stage with decreasing SES
was significant (p  0.001). Rural residence was
not associated with being diagnosed at a later
stage. Relative to non-Hispanic white women
with cervical cancer, African American and His-
panic women were more likely to be diagnosed
at a later stage (Table 2).
Table 3 and Figures 1 and 2 present the re-
sults from the survival analysis. Patients with
missing staging information (n  1169), no
available ZIP code date (n  116), with other/
unknown race/ethnicity (n  162), and listing
competing causes of death (n  323) were ex-
cluded, leaving 5467 women for the Cox pro-
portional hazards modeling and Kaplan-Meier
analyses. The demographic profile of women in-
cluded in the survival analysis was not statisti-
cally different from that of women in the full
sample. Kaplan-Meier survival curves (Figs. 1
and 2) limited to early and late stage disease,
respectively, indicate that lower SES is associ-
ated with reduced cervical cancer survival time
for women diagnosed in both early (log-rank
test chi-square  35.2, p  0.001) and late stage
disease (log-rank test chi-square  21.1, p value
0.001). Women diagnosed in late stage disease
were 6.2 times (adjusted HR 95% CI 5.5-7.2)
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TABLE 1. CHARACTERISTICS OF WOMEN DIAGNOSED WITH CERVICAL CANCER AND REPORTED
TO THE TEXAS CANCER REGISTRY, JANUARY 1995–JUNE 2001 (n  7237)
Characteristic Number % Cumulative %
Age, years
18–34 1250 17.3 017.3
35–44 1974 27.3 0044.6
45–54 1519 21.0 65.6
55–64 971 13.4 079.0
65 1523 21.0 100.0
Race/ethnicity
White non-Hispanic 3787 52.3 052.3
White Hispanic 2263 31.3 065.9
African American 983 13.6 097.2
Other/unknown 204 2.8 100.0
Year of diagnosis
1995 1161 16.0 016.0
1996 1184 16.4 032.4
1997 1108 15.3 047.7
1998 1104 15.3 063.0
1999 1067 14.7 077.7
2000 1041 14.4 092.1
2001 572 7.9 100.0
SEER staging
Stage IA–IB 3595 49.7 049.7
Stage IIA–IV 2473 34.2 083.9
Missing stage 1169 16.1 100.0
Cell type
Squamous cell 5249 72.5 072.5
Adenocarcinoma 1343 18.6 091.1
Rarea 129 1.8 092.9
Unknown morphology 516 7.1 100.0
aThose morphologies included as Rare cell types include sarcoma, carcinosarcoma, spindle cell sarcoma, small cell
sarcoma, large cell carcinoma, leiomyosarcoma, mixoid leiomyosarcoma, embryonal rhabdomyosarcoma, neuroen-
docrine carcinoma, and large cell neuroendocrine carcinoma.
Hosted in the Center for Research on Violence Against Women institutional repository with written permission from Mary Ann Liebert, publishers.
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TABLE 2. MULTIVARIATE PREDICTORS OF LATE STAGE CERVICAL CANCER DIAGNOSIS AMONG
5790a WOMEN REPORTED TO THE TEXAS CANCER REGISTRY, 1995–2001
Number Late stageb (%) Adjusted OR (95% CI)
5790 2377 (41.1) n  5790
Composite socioeconomic statusc
Low SES 1442 694 (48.1) 1.4 (1.2–1.7)d
Medium SES 1445 622 (43.0) 1.2 (1.1–1.5)d
High SES 1443 553 (38.3) 1.1 (1.0–1.3)d
Very High SES 1460 508 (34.8) 1.0 Refe
Trend test Z  4.49; p  0.001d
Rural residencec
70.00% rural 572 240 (42.0) 1.0 (0.8–1.2)d
23.33%–69.99% rural 973 393 (40.4) 0.9 (0.8–1.1)d
11.67%–23.32% rural 553 221 (40.0) 0.9 (0.7–1.1)d
0.01%–11.66% rural 1576 598 (37.9) 0.8 (0.7–0.9)d
Urban: 0% rural 2116 925 (43.7) 1.0 Ref
Trend test Z  0.6; p  0.55
Race/ethnicityc
African American 790 374 (47.3) 1.3 (1.1–1.6)d
Hispanic 1861 838 (45.0) 1.3 (1.1–1.5)d
White non-Hispanic 3139 1165 (37.1) 1.0 Ref
aWomen excluded from this analysis include those with no available ZIP code data, those of other/unknown
race/ethnicity, and those with missing stage at diagnosis.
bLate stage includes summary stages IIA–IV.
cOdds ratios are adjusted for age and other covariates in the table.
dp  0.05.
eRef, reference group.
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FIG. 1. Kaplan-Meier survival estimates: Early stage survival of cervical cancer patients by socioeconomic status.
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more likely to die than women diagnosed with
early stage disease (Table 3). 
Lower SES was associated with shorter cervi-
cal cancer cause-specific survival time among wo-
men with cervical cancer. The trend test for quar-
tiles of the composite SES variable and survival
time supports a dose-dependent association for
both early and late stage at diagnosis (Table 3).
Comparison of the lowest to highest SES quartile
and cervical cancer survival time indicates that
SES is associated with poor survival for both early
and late stage disease (early stage adjusted
aHR  3.0, 95% CI 2.1-4.3; late stage aHR  1.7,
95% CI 1.4-2.1). Moreover, when stage is treated
as a confounder in the model, low SES remains
associated with poor survival (aHR  1.9, 95% CI
1.6-2.3, p for trend 0.001).
Rural residence was not associated with cervi-
cal cancer survival in any stage of diagnosis
(Table 3). Furthermore, trend tests do not indi-
cate a dose-dependent relationship between the
degree of rural/urban residence and survival. In-
creased risk estimates for women living in areas
that are approximately 23%–70% rural are seen
across early, late, and all stages of diagnosis (all
stages, aHR  1.2, 95% CI 1.0-1.4; early stage
aHR  1.2, 95% CI 0.9-1.7; late stage aHR  1.2,
95% CI 1.0-1.5); however, these estimates did not
reach statistical significance.
Race/ethnicity remained associated with sur-
vival after adjusting for SES, rural residence, and
age. Relative to non-Hispanic white women,
African American women were 1.3 times (95% CI
1.1-1.5) more likely to die of cervical cancer in-
dependent of stage (Table 3). Hispanic women,
however, had a significant survival advantage
(aHR  0.7, 95% CI 0.6-0.8) relative to non-His-
panic white women that held for all stages at di-
agnosis (Table 3).
Results of this analysis show that both SES
and race/ethnicity affect cervical cancer sur-
vival after adjusting for stage at diagnosis and
age. In Table 4, we present analysis of SES and
cervical cancer survival within the three
racial/ethnic groups. SES continued to be asso-
ciated with cervical cancer survival in each
racial/ethnic group, with the most elevated risk
among Hispanic women living in areas of low
SES (aHR  2.2, 95% CI 1.5-3.3). Moreover,
trend tests reflect a dose-dependent association
between SES and survival within each racial/
ethnic group (Table 4).
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FIG. 2. Kaplan-Meier survival estimates: Late stage survival of cervical cancer patients by socioeconomic status.
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DISCUSSION
Minority race/ethnicity has consistently been
documented as a risk factor for later stage of cer-
vical cancer diagnosis.5,11,12,14,30–36 Our study
found that a lower composite SES and minority
race/ethnicity were associated with late stage at
diagnosis. Additionally, lower SES and African
American race were associated with poorer 
survival. Although Hispanic women were more
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TABLE 3. MULTIVARIATE PREDICTORS AND RELATIVE CERVICAL CANCER SURVIVALa (COX PROPORTIONAL HAZARDS
MODELING) AMONG 5467b WOMEN REPORTED TO THE TEXAS CANCER REGISTRY, 1995–2001
Death rate
(per 1000
women- All stagec Early staged Late staged
month) n  5467 n  3267 n  2200
Composite socioeconomic status in quartiles
Low SES 7.8 1.9 (1.6–2.3)* 3.0 (2.1–4.3)* 1.7 (1.4–2.1)*
Medium SES 7.0 1.6 (1.4–2.0)* 2.0 (1.4–2.9)* 1.5 (1.2–1.9)*
High SES 5.1 1.3 (1.1–1.6)* 1.4 (1.0–2.1) 1.3 (1.0–1.6)
Very High SES 3.5 1.0 Refe 1.0 Ref 1.0 Ref
Trend test Z  7.6, p  0.001* Z  6.5, p  0.001* Z  5.3, p  0.001*
Rural residence in quintiles
70.00% rural 6.3 1.0 (0.8–1.2) 0.8 (0.5–1.3) 1.1 (0.8–1.3)
23.33%–69.99% rural 7.0 1.2 (1.0–1.4) 1.2 (0.9–1.7) 1.2 (1.0–1.5)
11.67%–23.32% rural 6.1 1.1 (0.9–1.3) 1.2 (0.8–1.8) 1.0 (0.8–1.3)
0.01%–11.66% rural 4.7 0.9 (0.8–1.1) 0.9 (0.6–1.2) 0.9 (0.8–1.1)
Urban: 0% rural 5.8 1.0 Ref 1.0 Ref 1.0 Ref
Trend test Z  1.6, p  0.01 Z  0.4, p  0.67 Z  1.6, p  0.012
Race/ethnicity
African American 9.0 1.3 (1.1–1.5)* 1.1 (0.8–1.6) 1.3 (1.1–1.6)*
Hispanic 4.9 0.7 (0.6–0.8)* 0.7 (0.5–0.9)* 0.7 (0.6–0.8)*
White non-Hispanic 5.6 1.0 Ref 1.0 Ref 1.0 Ref
Stage at diagnosis
Late stage 4.5 6.2 (5.5–7.2)
Early stage 0.7 1.0 Ref 1.0 Ref 1.0 Ref
aAnalysis restricted to those reporting a death due to cervical cancer.
bWomen excluded from this analysis include those with no available ZIP code data, those of other/unknown
race/ethnicity, and those with missing stage at diagnosis.
cHRs adjusted for stage, age, and other covariates in the table.
dHRs adjusted for age and other covariates in the table.
eRef, reference group.
*p  0.05.
Adjusted HR (95% CI)
TABLE 4. SOCIOECONOMIC STATUS AND RELATIVE CERVICAL CANCER SURVIVALa BY RACE/ETHNICITY (COX PROPORTIONAL
HAZARDS MODELING) AMONG 5467b WOMEN REPORTED TO THE TEXAS CANCER REGISTRY, 1995–2001
Composite
socioeconomic status African American Hispanic White non-Hispanic
Low SES 2.0 (1.3–3.0)* 2.2 (1.5–3.3)* 1.6 (1.2–2.0)*
Mid-SES 1.8 (1.1–2.8)* 2.0 (1.3–3.0)* 1.5 (1.2–1.8)*
High SES 1.4 (0.8–2.1)* 1.3 (0.8–2.0)* 1.3 (1.0–1.6)*
Very high SES 1.0 Refd 1.0 Ref 1.0 Ref
Trend test p  0.001 p  0.001 p  0.001
aAnalysis restricted to those reporting a death due to cervical cancer.
bWomen excluded from this analysis include those with no available ZIP code data, those of other/unknown
race/ethnicity.
cHRs adjusted for age, stage, and rural residence.
dRef, reference group.
*p  0.05.
Adjustedc HR (95% CI)
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likely than non-Hispanic white women to present
help at a later stage, Hispanic cervical cancer pa-
tients were less likely to die of this disease. Fur-
thermore, the association between lower SES 
and poorer survival was consistent across all
racial/ethnic groups, suggesting the effect of SES
may be more important than race.
Our finding that lower SES was associated
with poorer survival, particularly among those
diagnosed at an early stage, is consistent with
the work reported by Mundt et al.,7 Morgan et
al.,6 and Johnson,5 who found that SES may be
an important predictor of survival after adjust-
ing for race/ethnicity. Further, our findings
concur with those of Singh et al.13 who found
that mortality increased with increasing
poverty for women in all racial/ethnic groups.
Five other studies found no association with
SES after adjusting for age and race/ethnic-
ity4,9–11 or stage of disease.21
The effect of rural residence as a proxy for ac-
cess to care may differentially affect stage at di-
agnosis and survival if access to screening ser-
vices is different from access to follow-up and
treatment services. We report no association be-
tween rural residence and stage at diagnosis or
survival, which contrasts with the strong associ-
ation between rural residence and cervical cancer
mortality (OR  19.4) reported by O’Brien et al.
in Australia.21 However, our findings concur
with those reported by Johnson5 for cervical can-
cer survival in South Carolina. Results of bor-
derline significance for the association between
women living in areas that are between 27% and
70% rural with reduced survival may indicate a
greater difficulty for these women to receive
treatment services. However, adequate treatment
data are necessary to explore these preliminary
results.
When adjusting for SES, our conclusion that
African American women were more likely to be
diagnosed at a late or unknown stage and to have
shorter survival times, particularly among those
diagnosed at a late or missing stage, is consistent
with the preponderance of the existing litera-
ture,4,9,12,13,15,17 yet four studies reported that
African American race was not an important pre-
dictor of survival after adjusting for socioeco-
nomic factors.3,5,10,11 Our finding that Hispanic
women were less likely to die of cervical cancer
compared with non-Hispanic white women
within any stage at diagnosis contrasts with the
two published studies with sufficient numbers
that report Hispanic ethnicity was not an inde-
pendent predictor of survival.13,30
Strengths and limitations of the study
A limitation to this study is the use of aggre-
gate (census) data as indicators for individual SES
and rural residence. However, defining rural res-
idence by ZIP code is not likely to cause misclas-
sification. Census tract residential conditions
based on the federal definition of rural and ur-
ban areas28 are not likely to vary greatly for in-
dividuals within a ZIP code. This may not be the
case for ZIP code-level proxies for SES. Census
tract-level data have been used to estimate the po-
tential effects of SES,10,12 yet these data were not
available to us. A recent study by Robert et al.,26
using the same components measures of SES used
here, reported that census tract level variables
were consistent with the effects of SES using ZIP
code-level variables. Our ZIP code-level data may
cause some misclassification relative to census
tract-level data, yet any misclassification will
likely bias the measure of association toward the
null. It is possible, however, that we could have
differential misclassification if lower SES women
were consistently misclassified as higher SES be-
cause of their ZIP codes. An analysis of the cor-
relation between the components of our compos-
ite SES measure revealed satisfactory correlation
(Cronbachs’ alpha  0.71), thus supporting accu-
rate categorization of women in respective SES
quintiles.
The use of death certificate information to de-
termine cause of death may contribute to out-
come misclassification for our cervical cancer sur-
vival analysis. This potential for bias is likely to
be nondifferential, as census data are not linked
with vital records. Exclusions for missing data
(e.g., those diagnosed by death certificate only)
may cause selection bias. However, our compar-
isons between the complete dataset and that used
for analyses did not show statistically significant
differences in the variables of interest. 
Using tumor registry or medical record data to
abstract race/ethnicity has the potential for mis-
classification. However, using data from both the
race and Spanish/Hispanic origin variables in-
creases accurate classification of race/ethnicity.
Accuracy between medical records and self-re-
port has reported to be moderate (Latinas) to high
(whites, Asians, and African Americans).37 Fur-
thermore, the TCR has strict guidelines outlined
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in the Texas cancer reporting handbook for iden-
tifying persons of Spanish or Hispanic origin.22
Other intervening variables not measured by
this model that may affect the association be-
tween SES factors and mortality include treat-
ment and presence of comorbid illnesses.38 Like
most cancer registries, the TCR was established
to provide a population-based estimate of cancer
incidence, not to provide validated treatment
data. Acquiring information on these variables
from outside sources will help to better under-
stand the relationship between factors associated
with decreased survival from cervical cancer. We
are looking toward future studies that will in-
clude data on these variables to supplement the
registry data.
Strengths of this study include its large sample
size (n  7346), which reduces random error and
increases study power. The use of a population-
based cancer registry reduces the potential for se-
lection bias by including all cervical cancer cases
in Texas. Evidence for case completeness includes
the reported TCR completeness proportion of
99% and the similar number of cervical cancer
cases reported per year to the TCR between 1997
and 2001 (1071)39 compared with the American
Cancer Society annual estimate for Texas in 2001
(1000).40
Future directions
Further studies are needed to replicate our find-
ing that Hispanic women with cervical cancer have
better survival relative to non-Hispanic white and
African American women. The well documented
Hispanic paradox41–43 indicates that regardless of
lower SES, the Hispanic population in the United
States has lower mortality rates. Reasons for this
advantage may include difference in social sup-
port, religion/faith, cultural influences, or health-
selective immigration differences between these
populations. Health-selective return migration of
immigrants may underestimate the mortality rates
in the United States,44 leading to an underascer-
tainment bias in Hispanic mortality rates from re-
search linked to the U.S. Death Index.
To address the possibility that Hispanic wo-
men with cervical cancer return to Mexico and
are, therefore, underreported as cases in the TCR,
we restricted the analysis to exclude women with
cervical cancer living along the Texas-Mexico
border (El Paso, Starr, Cameron, Hidalgo, and
Willacy counties). Hispanics relative to non-His-
panic white women still had a survival advan-
tage (aHR  0.8, 95% CI 0.7-0.9). This finding in-
dicates that selective migration back to Mexico
may not explain the strong protective effect of
Hispanic ethnicity on cervical cancer survival.
The findings reported here suggest that dis-
advantaged groups (e.g., African Americans or
people with low SES) may be at higher risk of
dying from a preventable (early stage) cancer.
Additional research on these high-risk groups
is needed to identify the missed opportunities
for preventing death among these women.
Missed opportunities may take the form of lo-
gistical/financial barriers (e.g., having no
transportation for treatment, not having insur-
ance, or insurance not covering care), commu-
nication barriers (e.g., language barriers be-
tween patient and healthcare provider or not
understanding options offered for treatment),
selective provision of healthcare by race/eth-
nicity, income, or rural residence (e.g., not of-
fering more aggressive treatment to someone
living in rural areas), and individual or cultural
differences in reaction to cervical cancer. As the
effect of SES was shown to be consistent across
all raceial/ethnic groups, interventions may be
more effective in reducing cervical cancer mor-
tality if these are developed to target women of
lower SES rather than by racial/ethnic groups.
Interventions can be developed to target high-
risk groups, for example, to ensure that state-
of-the-art treatment is offered and resources are
provided to overcome the impact of logistical
or financial barriers.
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